2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 2097

HLA-B27 Expression Profoundly Shapes the Host-Microbiota Metabolome
Abstract Number: 2922

HLA-Specific Antibody Profile in Renal Transplant Patients with Systemic LUPUS Erythematosus
Abstract Number: 1845

HMGB1 Early Marker in Lupus Nephritis
Abstract Number: 244

Hospitalization and Flare Risk in Patients with Established Gout: A Population-Based Study
Abstract Number: 2048

Hospitalization Trends of Rheumatoid Arthritis and Gout in the United States: A Crossroad
Abstract Number: 259

How Safe IT Is to TREAT Pregnant FMF Patients with Anakinra ?
Abstract Number: 2910

How Accurate Is Spot Urine Protein/Creatinine Ratio in Measuring the Change over Time in Proteinuria Level Compared to the 24 Hour Proteinuria Test?
Abstract Number: 1322

How Can We Reduce the Time for Scoring Radiographic Joint Damage in Rheumatoid Arthritis? Initial Results with a New Computer-Based Documentation Tool
Abstract Number: 1954

How Can We Use Ultrasound in the Diagnosis and Management of Patients with Giant Cell Arteritis?
Abstract Number: 3181

How Common Is Inactive Disease in a Prospective Cohort of Patients with Juvenile Idiopathic Arthritis? the Importance of Definition
Abstract Number: 2948

How Do Patients with Newly Diagnosed SLE Present? a Multicenter Cohort Analysis to Inform the Development of New Classification Criteria for SLE
Abstract Number: 1352

How Frequently Does Tuberculosis Screening Test Become Positive in Rheumatic Patients Treated with ANTI-Tumor Necrosis Factor-ALPHA Therapy? an Analysis of Risk Factors
Abstract Number: 1840

How Good a Job Are We Rheumatologists Doing in Screening for Hepatitis B and C before Immuno-Suppressive/s Initiation in SLE?
Abstract Number: 2335

How Much Does Fatigue Contribute to the Physician and Patient Global Estimates in Different Rheumatic Diseases? Analysis from Routine Care on a Multidimensional Health Assessment Questionnaire (MDHAQ)
Abstract Number: 2062

How Reliable Is Self-Evaluation of Symptoms of Inflammatory Back Pain By Patients?

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].